Acura Pharmaceuticals, Inc

Ownership Transactions Reported by 10 Insiders

Symbol
ACUR on OTC
Industry
Pharmaceutical Preparations
Location
616 N. North Court, Suite 120, Palatine, Illinois

There are no Buy or Sell transactions made by insiders since 6/2/2023

Acura Pharmaceuticals, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter A. Clemens Senior VP & CFO Nov 20, 2023
Immanuel Thangaraj Director Jan 2, 2024
William Skelly Director Jan 2, 2024
George Ross Director Jan 2, 2024
Bruce Wesson Director, Director Emeritus Jan 2, 2024
John Schutte More than 10% owner Jun 9, 2021
Abuse Deterrent Pharma, LLC More than 10% owner Jun 9, 2021
Robert A. Seiser VP, Treasurer & Controller Nov 20, 2023
Robert B. Jones President & CEO Nov 20, 2023
Albert W. Brzeczko VP, Pharmaceutical Sciences - APT Nov 20, 2023

Recent Insider Transactions by Companies or Individuals for Acura Pharmaceuticals, Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership